Stocks and Investing
Stocks and Investing
Thu, August 15, 2024
[ Thu, Aug 15th 2024
] - WOPRAI
[ Thu, Aug 15th 2024
] - WOPRAI
[ Thu, Aug 15th 2024
] - WOPRAI
[ Thu, Aug 15th 2024
] - WOPRAI
[ Thu, Aug 15th 2024
] - WOPRAI
[ Thu, Aug 15th 2024
] - WOPRAI
[ Thu, Aug 15th 2024
] - WOPRAI
[ Thu, Aug 15th 2024
] - WOPRAI
[ Thu, Aug 15th 2024
] - WOPRAI
[ Thu, Aug 15th 2024
] - WOPRAI
[ Thu, Aug 15th 2024
] - WOPRAI
[ Thu, Aug 15th 2024
] - WOPRAI
[ Thu, Aug 15th 2024
] - WOPRAI
[ Thu, Aug 15th 2024
] - WOPRAI
[ Thu, Aug 15th 2024
] - WOPRAI
[ Thu, Aug 15th 2024
] - WOPRAI
[ Thu, Aug 15th 2024
] - WOPRAI
[ Thu, Aug 15th 2024
] - WOPRAI
[ Thu, Aug 15th 2024
] - WOPRAI
[ Thu, Aug 15th 2024
] - WOPRAI
[ Thu, Aug 15th 2024
] - WOPRAI
[ Thu, Aug 15th 2024
] - WOPRAI
[ Thu, Aug 15th 2024
] - WOPRAI
[ Thu, Aug 15th 2024
] - WOPRAI
[ Thu, Aug 15th 2024
] - WOPRAI
[ Thu, Aug 15th 2024
] - WOPRAI
[ Thu, Aug 15th 2024
] - WOPRAI
[ Thu, Aug 15th 2024
] - WOPRAI
[ Thu, Aug 15th 2024
] - WOPRAI
Jason Zemansky Maintained (SNDX) at Strong Buy with Increased Target to $31 on, Aug 15th, 2024
Jason Zemansky of B of A Securities, Maintained "Syndax Pharmaceuticals, Inc." (SNDX) at Strong Buy with Increased Target from $30 to $31 on, Aug 15th, 2024.
Jason has made no other calls on SNDX in the last 4 months.
There are 4 other peers that have a rating on SNDX. Out of the 4 peers that are also analyzing SNDX, 0 agree with Jason's Rating of Hold.
These are the ratings of the 4 analyists that currently disagree with Jason
- Anupam Rama of "JP Morgan" Maintained at Buy with Decreased Target to $33 on, Tuesday, August 6th, 2024
- Kelly Shi of "Jefferies" Initiated at Strong Buy and Held Target at $37 on, Friday, June 28th, 2024
- Bradley Canino of "Stifel" Maintained at Strong Buy with Increased Target to $42 on, Wednesday, June 26th, 2024
- Yigal Nochomovitz of "Citigroup" Maintained at Strong Buy with Decreased Target to $30 on, Thursday, May 9th, 2024
Contributing Sources